Resources

Review of the Narcotic Drugs Act 1967 - Final report authored by Professor John McMillan AO, published on 10 July 2019.

Information on how the Office of Drug Control implements cost recovery for regulatory activities.

A total of 50 submissions were received in response to the public consultation between 22 Feb to 22 March 2019. Read the published submissions.

The 2016 amendments to the ND Act included a requirement in section 26A that the Minister cause a review of the operation of the Act to be undertaken as soon as possible after the second anniversary of the commencement of the 2016 amendments.

The Australian Government is exploring the appropriate mechanism to increase the quantity of kava that may be imported into Australia by incoming passengers for personal use.

Update to guidance on sponsored import and supply of unregistered medicinal cannabis products.

Policy Circular #03/17

Policy Circular #02/17

Policy Circular #01/17

Application form for a licence to export precursor substances controlled under Regulation 10AB of the Customs (Prohibited Exports) Regulations 1958.

The Customs (Prohibited Exports) Regulations 1958 allow for export of prohibited substances with permission of administering agencies.

Information on how ODC implements cost recovery for regulatory activities (2016).

The Narcotic Drugs Regulation 2016 gives effect to licensing the cultivation and production of cannabis and cannabis resins for medicinal and scientific purposes and drugs as provided for under the Narcotic Drugs Act 1967.

The Narcotic Drugs Legislation Amendment Act 2016 protects sensitive law enforcement information used in assessing cannabis licence applications.

The Narcotic Drugs (Licence Charges) Act 2016 enables the Office of Drug Control to accept annual charges from cannabis licence holders.

Medicinal cannabis cost modelling is an independent report commissioned by the Department of Health,

Presentation regarding the Commonwealth Medicinal Cannabis Initiative, delivered at an information session on 4-16 October 2016.

A summary of questions and responses put at the July 2016 Consultation and Information Sessions about the Medicinal Cannabis Scheme.

Commonwealth Medicinal Cannabis Initiative (Information and consultation sessions) presented 11-20 July 2016.

Presentation regarding the Commonwealth Medicinal Cannabis Initiative, delivered at an information session on 11-20 July 2016.

The Convention on Psychotropic Substances establishes an international control system for psychotropic substances.

The Single Convention aims to combat drug abuse by coordinated international action.

This Convention provides comprehensive measures against drug trafficking, including provisions against money laundering and the diversion of precursor chemicals.

Application form for a licence to import and/or export narcotic psychotropic and precursor substances.

Application form for a medicinal cannabis permit – manufacture.